HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.K. E-Cigarettes Can Make Smoking Alternative Claim, But Not Healthier

This article was originally published in The Tan Sheet

Executive Summary

NJOY ads “implied that the product was favorable to smoking tobacco cigarettes,” but “there may be a number of reasons why a friend might suggest the product as an alternative to smoking tobacco cigarettes,” U.K. advertising watchdog says.

You may also be interested in...



U.K. Packages All Electronic Cigarettes Under Medical Regulation

The U.K. pharma regulator requires all electronic cigarettes to be licensed as nonprescription medicines beginning in 2016, noting concerns about product quality. Meanwhile, FDA considers allowing e-cigarettes to be marketed as nicotine replacement therapy on a case-by-case basis.

Classifying E-Cigarettes As Tobacco Snuffs Out Cessation Utility – FDA

FDA makes a case for regulating electronic cigarettes as nicotine-replacement therapies, calling the products "a promising tool" in controlling tobacco use.

Durbin Lights Supplement MPL Flare In US Senate

Senate votes down Illinois Democrat’s proposal to amend stopgap appropriations bill with language calling for establishing mandatory products listing program in FDA. But proposal to give FDA MPL authority likely will return in Congress, says Natural Products Association.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS123865

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel